After Decades Of Killing Us & Making Us Sicker, It Looks Like Big Pharma Is Finally On the Way Out

Big Pharma Lobbying Against Cannabis

A new survey released this month in the Journal of Psychoactive Drugs helps clarify why Big Pharma is indeed frightened of cannabis. The alcohol and pharmaceutical industries, both powerful influences in Washington, have long lobbied against cannabis legalization in order to secure their gains.

However, the tide has turned as decriminalization of medical and recreational cannabis sweeps the country and the continent. With legalization, an increasing number of people are discovering this plant could provide a safe solution to the dangerous effects of prescription tablets.

Researchers recently dispersed 400 questionnaires to medical marijuana patients at a public event asking them about their use and attitudes toward the U.S. health care system. The results of the survey were printed in the Journal of Psychoactive Drugs.

Most of them said that cannabis represented an effective and comparatively harmless alternative to pharmaceuticals that are conventionally prescribed for their various conditions.

“In comparison with pharmaceutical medications, medical cannabis users rated cannabis better on efficacy, side effects, security, addictiveness, accessibility, and cost,” the study found. “Because of the medical use of cannabis, 42 percent ceased taking a pharmaceutical drug and 38 percent utilized of a pharmaceutical drug.”

Highlighting the prospect of marijuana to suppress the country’s drug problem, the most common medication patients reported quitting or reducing using were opioid-based painkillers, non-opioid painkillers, benzodiazepines and anti-depressants.

Since TFTP has reported, this massive shift from frequently dangerous prescription medication to cannabis has been recorded for some time now and is likely creating a tide of dread int he pharmaceutical industry. We reported a survey conducted by the Centre for Addictions Research of BC at 2016 which saw similar results.

Strong Numbers In Support of Cannabis

The survey of 473 adult therapeutic cannabis consumers found that 87% of respondents gave up prescription medications, alcohol, or other drugs in favor of cannabis. Adults under 40 were likely to give up all three of them for medical cannabis.

The startling revelation, and one that will have Big Pharma running with their crony lawmakers, is that 80 percent of respondents reported substituting cannabis for pharmaceutical medication.Additionally, 52% said they substituted cannabis for alcohol and 32 percent said they substituted it for illicit substances. These results indicate a very promising trend of people moving from dangerously addictive and deadly substances in favor of a miracle plant that has never caused an overdose death.

“The finding that cannabis has been substituted for three classes of substances suggests that the clinical use of cannabis may play a harm reduction part in the circumstance of use of those substances, and might have implications for abstinence-based substance use treatment approaches. Additional research should seek to distinguish between biomedical substitution for prescription pharmaceuticals and psychoactive drug substitution, and to elucidate the mechanisms behind both.”

As The Free Thought Project has reported before, the U.S. is in the midst of a painkiller outbreak , with overdose deaths skyrocketing as Big Pharma has secured its grip on government and mainstream medication.

The outcomes of this survey confirm that cannabis is your reply to each these issues.

Americans for Safe Access has a thorough breakdown of conditions that cannabis can treat, and comparisons to prescription tablets.

We are just starting to affirm the advantages of cannabis on different conditions such as stress that’s normally treated with pills like Xanax, insomnia which is normally treated with pills like Ambien, and antidepressants which are treated with pills like Zoloft. Every one these prescription drugs can cause debilitating addiction or acute side-effects.

Although the war on drugs put a halt to clinical cannabis study for decades, in recent years we have seen a spike in studies being performed, as prohibition crumbles along with the Schedule 1 classification of”no medical advantage” is exposed as a farce.

Related Posts


Stay up to date with the latest news